News Articles

Read our news stories to stay up to date on our research, the latest discoveries, and other MHIF updates.

triclip team
Valve Disease

MHIF research milestone đź’“ FDA approves device used as alternative to open-heart surgery

KSTP-TV News Feature—TriClip Device for Tricuspid Regurgitation

The Minneapolis Heart Institute Foundation team is honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the last week, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology.
MHIF at ACC
Research

MHIF Research at American College of Cardiology (ACC) Scientific Sessions 2024

The American College of Cardiology Annual Scientific Session (ACC.24) is held in Atlanta, April 6 – 8, 2024. This international gathering is focused on everything in cardiovascular care, including the latest in science and innovation, and practice-changing updates in care. MHIF is well represented in 43 sessions at ACC.24.
triclip
Valve Disease

A New Treatment for Leaky Tricuspid Valves

And the Research that Made this Advance Possible for Patients!

Today, a new therapy is available for patients following years of lifesaving heart research. Minneapolis Heart Institute Foundation announced an important research milestone with the U.S. Food and Drug Administration (FDA) approval of the TriClip™ (manufactured by Abbott).
stethoscope and uterus
Women's Heart Research

What women need to know about birth control, sleep and heart disease

When women consider self-care, images of a soothing facial or massage may come to mind. Vacation scenes of sun and beach, lake and cabin might also surface, or a night out with best friends. While those options are delightful choices, another kind of self-care may be far more important: protecting the heart.

Heart disease kills more women than all forms of cancer, Alzheimer’s, and respiratory diseases combined. More women than men die from heart disease each year.

Press Releases

Minneapolis Heart Institute Foundation® Announces First Patient Enrolled in VISTA U.S. Study Evaluating Novel Tricuspid Valve Replacement Technology

Minneapolis Heart Institute Foundation® (MHIF) today announced the first enrollment in the VISTA U.S. early feasibility study offering a new transcatheter tricuspid valve technology for severe tricuspid valve regurgitation.

Research Data Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks│American College of Cardiology's Scientific Session (ACC.24)

The Minneapolis Heart Institute Foundation® (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the upcoming American College of Cardiology's meeting Annual Scientific Session (ACC.24).

Minneapolis Heart Institute Foundation Announces Research Milestone with FDA Approval of TriClip™, First-of-Its-Kind Device for Patients with Leaky Tricuspid Heart Valve

Minneapolis Heart Institute Foundation® (MHIF) today announced an important research milestone with the U.S. Food and Drug Administration (FDA) approval of the TriClip™ (manufactured by Abbott), a first-of-its-kind, non-surgical, transcatheter edge-to-edge repair (TEER) system.

Sign Up For Our Newsletter

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.

CAPTCHA
MHIF Logo

Donate

Contact us

Minneapolis Heart Institute Foundation
920 East 28th Street, Suite 100
Minneapolis, MN 55407

Email: info@mhif.org
Phone: 612-863-3833
Toll Free: 877-800-2729
Fax: 612-863-3801

Connect with us

Follow us on social media for the latest news and updates!

Sign up for our newsletter

Privacy Policy  © Minneapolis Heart Institute Foundation 2024

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.

Read More